Medical Journals

Subversion of Innate and Adaptive Immune Responses by Toxoplasma Gondii.

Authors:
  • Lang Christine
  • Gross Uwe
  • Lüder Carsten G K

From: Institute for Medical Microbiology, Georg-August-University, Kreuzbergring 57, Göttingen, Germany.

Parasitology research

  • Publish Date: Jan 2007
  • ISSN: 0932-0113
  • Volume: 100
  • Issue: 2
  • Pages: 191-203
  • Medium: Print
  • Language: English
  • Citation (JAMA): Lang Christine, Gross Uwe, Lüder Carsten G K, et al. Subversion of Innate and Adaptive Immune Responses by Toxoplasma Gondii.. Parasitol. Res. Jan 2007;100:191-203

Abstract

The intracellular apicomplexan parasite Toxoplasma gondii is able to survive and persist in immunocompetent intermediate hosts for the host’s life span. This is despite the induction of a vigorous humoral and — more importantly — cell-mediated immune response during infection. In order to establish and maintain such chronic infections, however, T. gondii has evolved multiple strategies to avoid or to interfere with potentially efficient anti-parasitic immune responses of the host. Such immune evasion includes (1) indirect mechanisms by altering the expression and secretion of immunomodulatory cytokines or by altering the viability of immune cells and (2) direct mechanisms by establishing a lifestyle within a suitable intracellular niche and by interference with intracellular signaling cascades, thereby abolishing a number of antimicrobial effector mechanisms of the host. Despite the parasite’s ability to interfere successfully with the host’s efforts to eradicate the infection, the immune response is, however, not completely abrogated but is rather partially diminished after infection. T. gondii thus keeps a delicate balance between induction and suppression of the host’s immune response in order to guarantee the survival of the host as a safe harbor for parasite development and to allow its transmission to the definitive host.

Mesh Headings (Keywords): Animals, Cytokines, Humans, Immunity, Natural, Toxoplasma, Toxoplasmosis


Check for Full Text / PubMed Unique Identifier (PMID): 17024357


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.